Dr. Benedikt Lopez

Pathologist · UCLH · United Kingdom (GB) · Oncology

Tier 3STK-0065GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Elderly patients
Engagement preference: Virtual
Advisory boards: 1
Publications: 2
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 14 Aug 2026 (32 days ago)
Next planned contact: 14 Aug 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
14 Aug 2026	Scientific exchange	Virtual	James Whitfield	Vantrexa	PD-L1 testing turnaroundBrain-metastasis subgroup data+1	0	—	Reviewed	ENG-0106

Timeline

14 Aug 2026
Scientific exchange
PD-L1 testing turnaround, Brain-metastasis subgroup data, Comparator checkpoint monotherapy

Related stakeholders (7)

UCLH

Dr. Chloé Dubois
Oncology pharmacist
Tier 3
Dr. William Vogel
Pathologist
Tier 3
Dr. Zoë Castellano
Renal pathologist
Tier 2
Dr. Daniel Kimura
Academic nephrologist
Tier 2
Dr. Tomoko Jensen
Renal pathologist
Tier 2
Dr. Gabriel Kimura
Dermatologist
Tier 1
Dr. Javier Tanaka
Dermatologist
Tier 3